Cargando…
Nanotherapy: New Approach for Impeding Hepatic Cancer Microenvironment via Targeting Multiple Molecular Pathways
OBJECTIVE: Hepatocellular carcinoma (HCC) microenvironment has been recognized as a key contributor for cancer progression, metastasis, and drug resistance. The crosstalk between tumor cells, the vascular endothelial growth factor (VEGF), and the chemokine (C-C motif) ligand 2 (CCL2) signaling netwo...
Autores principales: | Abd-Rabou, Ahmed A, Ahmed, Hanaa H, Mohamed, Safaa H, Kotob, Soheir E, Kishta, Mohamed S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971455/ https://www.ncbi.nlm.nih.gov/pubmed/36580009 http://dx.doi.org/10.31557/APJCP.2022.23.12.4261 |
Ejemplares similares
-
Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer-labeled viramidine nanoparticles
por: Abd-Rabou, Ahmed A., et al.
Publicado: (2022) -
Newly Synthesized Punicalin and Punicalagin Nano-Prototypes Induce Breast Cancer Cytotoxicity Through ROS-Mediated Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2022) -
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
por: Abd-Rabou, Ahmed A., et al.
Publicado: (2023) -
Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018) -
Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2019)